Skin Autofluorescence May Contribute to Prediction of Low Bone Quality in Type 1 Diabetes—A Clinical Cross‐Sectional Study
Diabetes/Metabolism Research and Reviews · 2025
DOI: 10.1002/dmrr.70080 ↗At a glance
Journal article in Diabetes/Metabolism Research and Reviews, 2025. Written by Inge Agnete Gerlach Brandt and 4 co-authors. Institution: Steno Diabetes Center North Denmark, Aalborg, Denmark. Major MEDLINE topics: Diabetes Mellitus, Type 1, Skin, Bone Density, Osteoporosis. Cited 1 times so far (Crossref); 58 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Novo Nordisk Foundation.
Topics: Diabetes mellitus
Abstract (original language)
Introduction
People with type 1 diabetes are at risk of complications, including impaired bone health. Hyperglycaemia and accumulation of advanced glycation end products (AGEs) are involved in the development of those. Bone measurements such as trabecular bone score (TBS), high‐resolution periphery quantitative computed tomography (HR‐pQCT), and impact microindentation may detect impaired bone health better than bone mineral density (BMD). Clinical measures reflecting risk factors such as AGE accumulation or prevalence of cardiovascular autonomic neuropathy may also predict low bone quality.
Methods
This cross‐sectional study included 111 adults with type 1 diabetes and 37 healthy sex‐ and age‐matched. Bone health was assessed through DXA with TBS, HR‐pQCT and impact microindentation. Accumulation of AGEs was evaluated by skin autofluorescence, and screening for cardiovascular autonomic neuropathy was performed.
Results
The mean (SD) age of the participants was 42.3 (13.8) years and the median (IQR) BMI was 26.9 [24.5; 30.1] kg/m 2 . Median SkinAGE value was higher in the type 1 diabetes group (2.1 [1.9; 2.7]) than in the control group (1.8 [1.6; 2.3]), p = 0.004. In the diabetes group, SkinAGE correlated with femoral neck, total hip BMD, and TBS. SkinAGE showed predictive value for low TBS upon adjustment for age, sex, and BMI.
Conclusion
In persons with type 1 diabetes, higher levels of AGE accumulation measured by skin autofluorescence are related to a lower BMD as well as a lower TBS. Along with consideration of age, sex, BMI and other risk factors of osteoporosis, a high skin autofluorescence should increase the suspicion of impaired bone health.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Steno Diabetes Center North Denmark, Aalborg, Denmark.
- Aalborg University Hospital, Aalborg, Denmark.
- Aalborg University, Aalborg, Denmark.
- University of Southern Denmark, Odense, Denmark.
- Department of Endocrinology, University Hospital, Esbjerg, Denmark.
- Steno Diabetes Center Odense, Odense, Denmark.
ORCID profiles: Inge Agnete Gerlach Brandt
Funding
- Novo Nordisk Foundation
Cite
APA
Brandt, I. A. G., Vestergaard, P., Frost, M., Juhl, C. B., & Harsløf, T. (2025). Skin Autofluorescence May Contribute to Prediction of Low Bone Quality in Type 1 Diabetes—A Clinical Cross‐Sectional Study. Diabetes/Metabolism Research and Reviews. https://doi.org/10.1002/dmrr.70080
Vancouver
Brandt IAG, Vestergaard P, Frost M, Juhl CB, Harsløf T. Skin Autofluorescence May Contribute to Prediction of Low Bone Quality in Type 1 Diabetes—A Clinical Cross‐Sectional Study. Diabetes/Metabolism Research and Reviews. 2025. doi:10.1002/dmrr.70080
BibTeX
@article{Brandt2025,
author = {Brandt, Inge Agnete Gerlach and Vestergaard, Peter and Frost, Morten and Juhl, Claus Bogh and Harsløf, Torben},
title = {Skin Autofluorescence May Contribute to Prediction of Low Bone Quality in Type 1 Diabetes—A Clinical Cross‐Sectional Study},
journal = {Diabetes/Metabolism Research and Reviews},
year = {2025},
doi = {10.1002/dmrr.70080}
}
EUVIMED